Home
/
Treatment
/
5-aza-2′-dexocytidine combined with 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one

5-aza-2′-dexocytidine combined with 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one

	5-aza-2′-dexocytidine combined with 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one
Trade Name
Orphan Indication	Thalassemia
USA Market Approval	USA
USA Designation Date	2017-02-16 00:00:00
Sponsor	EpiDestiny Inc.;7536 Royal Portrush Drive;Solon, Ohio, 44139